SC

Subhash Chandra Sahu

Active Director Managing Director DIN 00828734
DIN 00828734 First appointment Nov 1975 Primary industry Food and Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Nov 1975
Shareholding value •••• Premium profile

About Subhash Chandra Sahu

Data last updated:

Subhash Chandra Sahu is a Managing Director at Umeri Distillery Private Limited (since 1989), Director at Abicee Pharmaceuticals Pvt Ltd (since 2013) and Director at Ganga Devi And Sons Pvt Ltd (since 1975). The companies operate in Food and Beverages, Pharma and Travel and Hospitality. The 3 current companies with reported revenue have a combined latest revenue of ₹29.16 Cr; the largest is Umeri Distillery Private Limited at ₹19.25 Cr (FY 2025). Earlier, Subhash Chandra Sahu was a Director at Sahu Gases Ltd (from 1981) and Director at Jeypore Green Valley Projects Private Limited (from 2009).

DIN 00828734
Primary Designation Managing Director
Industry Food and Beverages
First Appointment 10 Nov 1975
Oldest Company Age 50 yrs
Largest company Umeri Distillery Private Limited · ₹19.25 Cr (FY 2025)
Combined revenue ₹29.16 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Umeri Distillery Private Limited U45201OR1985PTC006912
Managing Director08 Jun 19891985₹19.25 Cr (FY 2025)Active
Abicee Pharmaceuticals Pvt Ltd U15549OR1984PTC001404
Director08 Feb 20131984₹9.03 Cr (FY 2023)Active
Ganga Devi And Sons Pvt Ltd U55101OR1975PTC000680
Director10 Nov 19751975₹87.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sahu Gases Ltd U24111OR1981PLC000982
Director15 Sep 19811981Strike Off
Director03 Nov 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sahu Gases Ltd
Abicee Pharmaceuticals Pvt Ltd
Umeri Distillery Private Limited
Ganga Devi And Sons Pvt Ltd
Premium access

Shareholding and investment profile for Subhash Chandra Sahu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Chandra Sahu

Subhash Chandra Sahu currently holds 3 directorships: Umeri Distillery Private Limited (Managing Director, since 08 Jun 1989, revenue ₹19.25 Cr (FY 2025)); Abicee Pharmaceuticals Pvt Ltd (Director, since 08 Feb 2013, revenue ₹9.03 Cr (FY 2023)); Ganga Devi And Sons Pvt Ltd (Director, since 10 Nov 1975, revenue ₹87.3 Lakh (FY 2025)).

Subhash Chandra Sahu was first appointed on 10 Nov 1975 as Director at Ganga Devi And Sons Pvt Ltd. The most recent appointment on record is 08 Feb 2013 at Abicee Pharmaceuticals Pvt Ltd.

The 3 current companies of Subhash Chandra Sahu that report revenue have a combined latest revenue of ₹29.16 Cr: Umeri Distillery Private Limited ₹19.25 Cr (FY 2025); Abicee Pharmaceuticals Pvt Ltd ₹9.03 Cr (FY 2023); Ganga Devi And Sons Pvt Ltd ₹87.3 Lakh (FY 2025).

Subhash Chandra Sahu held 2 earlier board appointments: Sahu Gases Ltd (Director, from 15 Sep 1981); Jeypore Green Valley Projects Private Limited (Director, from 03 Nov 2009).

The current boards of Subhash Chandra Sahu's companies include Namrata Sahu (Umeri Distillery Private Limited), Sandeep Sahu (Umeri Distillery Private Limited), Shekhar Sahu (Abicee Pharmaceuticals Pvt Ltd), Shubhra Sahu (Abicee Pharmaceuticals Pvt Ltd), Amar Kumar Sahu (Ganga Devi And Sons Pvt Ltd), Deepak Kumar Sahu (Ganga Devi And Sons Pvt Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available